# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-23T22:07:29.456859
**Route:** OpenRouter + LaTeX
**Paper Hash:** 3a3f3113e9f9da09
**Tokens:** 22371 in / 1255 out
**Response SHA256:** ece815780a866988

---

No fatal errors detected under the four categories you specified. The empirical design is feasible with the stated data coverage, the regression outputs look numerically sane (no impossible values / explosive SEs / missing entries), required table elements (SEs, Ns) are present, and I did not find clear internal contradictions that rise to the level of “cannot be true given the paper’s own tables/claims.”

Points I checked explicitly (to ensure no hidden fatal misalignment):

- **Treatment timing vs. data coverage:** OZ treatment begins in **2018**; outcomes use **2015–2017** as pre and **2019–2023** as post. Data sources listed (ACS 2011–2015 running variable; LODES 2015–2023; EIA/EPA facility data) are consistent with those windows.
- **Post-treatment observations:** Yes—there is a post period for all outcomes (2019–2023). (This is RDD, not DiD cohorts.)
- **RDD feasibility:** Design is at the **20% poverty cutoff** with observations on both sides; multiple tables report left/right windows and donut variants, so there is support on both sides.
- **Regression sanity across tables:** All reported **SE magnitudes** look plausible given units; no R² outside [0,1]; no NA/NaN/Inf; no negative SEs; no missing N.
- **Completeness:** No “TBD/TODO/XXX/NA” placeholders in tables; all referenced core tables/figures in the provided source appear to exist (by label) and key analyses described in the text are actually reported somewhere in the draft (main, donut, placebo, kernels, inference robustness, local randomization, DC robustness, vintage).

ADVISOR VERDICT: PASS